- An Ohio court will hold a hearing on Oct. 4 where it will likely formally approve a $124M settlement in a shareholder derivatives lawsuit against Cardinal Health ( NYSE: CAH ).
- Shareholders claimed that the company failed to adequately protect itself from liability related to the opioid crisis.
- The settlement was first reached on May 25.
- Cardinal Health ( CAH ), like other wholesale drug distributors, has paid out hundreds of millions of dollars in settlements to states related to the opioid crisis.
For further details see:
Cardinal Health $124M shareholder derivative settlement set for October court approval